A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
Clinical trial NCT07570979 · RECRUITING
Trial details
- NCT number
- NCT07570979
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-25
- Primary completion
- 2030-06-03
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.